Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03970330 · ClinicalTrials.gov registry record · Phase 3
Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 9
- Enrollment target
NCT03970330 is a Phase 3 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 9 participants.
The verdict
NCT03970330, a Phase 3 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the addition of Low Dose Naltrexone to standard endometriosis treatments will improve patient reported endometriosis associated pain.
Interventions
- DRUG Placebo
- DRUG Norethindrone Acetate
- DRUG Naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-01-16 |
| Est. Completion | 2021-06-21 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03970330
The ClinicalTrials.gov registry entry for NCT03970330 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03970330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03970330 about?
NCT03970330 is a clinical study titled "Low-Dose Naltrexone in Combination With Standard Treatment in Women With Endometriosis". The purpose of this study is to determine if the addition of Low Dose Naltrexone to standard endometriosis treatments will improve patient reported endometriosis associated pain.
What is the current status of trial NCT03970330?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 9 participants. The study started on 2020-01-16. Estimated completion is 2021-06-21.
What interventions are being tested in trial NCT03970330?
The interventions under investigation include: Placebo (DRUG), Norethindrone Acetate (DRUG), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT03970330?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.